Found 557 matching trials
BrEto-TCL - Defining the Role of Brentuximab and Etoposide for Optimizing First-line Therapy of T-cell Lymphomas PHASE3 There is no data comparing the effectiveness of the 4 most relevant first-l...
Show More Status
Enrolling By Invitation
Location
Multiple Locations
Learn More & Join Trial
A Study of PET Adapted Therapy and Non-invasive Monitoring for Previously Untreated Limited Stage Diffuse Large B Cell Lymphoma PHASE2 The overarching goals of this study are to measure levels of circulating tu...
Show More Location
University of Rochester
Learn More & Join Trial
Pegfilgrastim and Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Aggressive B-Cell Non-Hodgkin Lymphoma PHASE2 RATIONALE: Drugs used in chemotherapy, such as cyclophosphamide, doxorubici...
Show More Location
Multiple Locations
Learn More & Join Trial
Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma PHASE2 This is a prospective single arm, multi-center, phase II clinical trial to ...
Show More Location
Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university
Learn More & Join Trial
Efficacy and Safety of Lenalidomide Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma PHASE2 This study aims to compare the efficacy and safety of lenalidomide plus CHO...
Show More Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial
SWOG-9320 Combination Chemotherapy, Radiation Therapy, and Antiviral Therapy in Treating Patients With AIDS-Related Lymphoma PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Show More Location
MBCCOP - University of South Alabama
Learn More & Join Trial
Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma PHASE3 RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Show More Location
Haematologisch Onkologische Praxis
Learn More & Join Trial
Evaluation of Treatment by Glofitamab in Combination With Rituximab or Obinutuzumab Plus CHOP in Patients With RIchter Syndrome PHASE2 This is a national clinical trial, multicentric (28 centers), non-randomize...
Show More Location
Amiens-Picardie Chu
Learn More & Join Trial
Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011) PHASE1 This pilot clinical trial studies the side effects of pegaspargase when giv...
Show More Location
Phoenix Childrens Hospital
Learn More & Join Trial
Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma PHASE2 The goal of this clinical research study is to learn if a chemotherapy comb...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial